Three ORTEX Signals Align on ICICI Bank
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

Why this matters — Three distinct ORTEX data streams — short interest, cost to borrow, and options sentiment — have converged on IBN within a single week. The signals point in conflicting directions, making the setup worth close attention.
Converging Signals
Short interest collapses. Shares short fell 12.6% in a single day on April 24, dropping to 23.8 million. The weekly decline stands at 12.1%. Over the past month, short interest has fallen 14.6%. Days to cover sits at 3.83, down sharply from above 7 in late February. Short sellers are exiting at an accelerating pace.
Cost to borrow firms up. Even as short interest falls, borrow costs rose 52% over the week to 0.52% before settling back to 0.40% by April 24. The 1-month change is +5.0%. This divergence — fewer shares short but rising borrow cost — suggests the remaining short positions are becoming harder to maintain. Utilisation stands at 1.21%, far below the 52-week high of 7.01%.
Options market turns decisively bullish. The put/call ratio hit 0.561 on April 24. That is nearly 1.9 standard deviations below the 20-day mean of 0.69. The shift began around April 21, with the PCR dropping sharply from the 0.72–0.74 range that held through most of March and early April. Call buyers now dominate the options flow.
Corroborating Context
Factor scores reinforce the constructive picture. EPS momentum ranks in the 97th percentile over 30 days and the 95th percentile over 90 days. The analyst recommendation differential ranks 92nd percentile. ICICI Prudential Asset Management added 44.0 million shares in Q1 2026. BlackRock added 8.4 million in the same period. Both moves suggest institutional conviction is building, not fading.
Historical Parallel
The PCR last dropped to comparable lows in March 2026 — hitting 0.45–0.48 — before the stock pulled back modestly. That episode preceded a cost-to-borrow spike above 0.75%. The current setup echoes that pattern: a sharp PCR drop paired with CTB volatility, though short interest this time is considerably lower.
Data Summary
- Shares short: 23.8M as of April 24 — down 12.6% in one day, down 14.6% over the month
- Put/call ratio: 0.561 — 1.87 standard deviations below the 20-day mean of 0.69
- Cost to borrow: 0.40% (April 24), up ~11.7% week-on-week; intra-week spike to 0.52%
- Utilisation: 1.21% vs. 52-week high of 7.01%
- Days to cover: 3.83 (official FINRA data, settlement date April 15)
- EPS momentum: 97th percentile (30-day), 95th percentile (90-day)
- Analyst rec differential: 92nd percentile
- ICICI Prudential added 44.0M shares in Q1 2026; BlackRock added 8.4M
- Price: $27.60, up 6.0% over the past month; ORTEX short score 32.4/100
Against its own history
This week's change in short interest is 2.1 standard deviations below the company's typical weekly move over the past year.
Stocks in this article
See the live data behind this article on ORTEX.
Open IBN on ORTEX →How this article was generated
- Generated
- 27 Apr 2026, 11:11
- Data as of
- 27 Apr 2026, 11:04
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signals
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.